Evidence map›Paper›PMID 33156570›Full record

ArticleAging cell2020

FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16

Jessica Voisin, Francesca Farina, Swati Naphade, Morgane Fontaine, Kizito-Tshitoko Tshilenge, Carlos Galicia Aguirre, Alejandro Lopez-Ramirez, Julia Dancourt, Aurélie Ginisty, Satish Sasidharan Nair and 7 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Jessica VoisinCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Francesca FarinaCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Swati NaphadeBuck Institute for Research on Aging, Novato, CA, USA.
Morgane FontaineCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Kizito-Tshitoko TshilengeBuck Institute for Research on Aging, Novato, CA, USA.
Carlos Galicia AguirreBuck Institute for Research on Aging, Novato, CA, USA.
Alejandro Lopez-RamirezBuck Institute for Research on Aging, Novato, CA, USA.
Julia DancourtCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Aurélie GinistyCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Satish Sasidharan NairCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Kuruwitage Lakshika MadushaniBuck Institute for Research on Aging, Novato, CA, USA.
Ningzhe ZhangBuck Institute for Research on Aging, Novato, CA, USA.
François-Xavier LejeuneCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Marc VernyCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.
Judith CampisiBuck Institute for Research on Aging, Novato, CA, USA.ORCID 0000-0001-6858-9462
Lisa M EllerbyBuck Institute for Research on Aging, Novato, CA, USA.
Christian NeriCentre National de la Recherche Scientifique UMR 8256, Institut National de la Santé et de la Recherche Médicale ERL U1164, Assistance Publique-Hôpitaux de Paris, Brain-C Lab, Sorbonne Université, Paris, France.ORCID 0000-0002-3790-2978
Inserm · FRBuck Institute for Research on Aging · US

Funding

Training in Basic Research on Aging and Age-Related DiseaseT32AG000266 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Lisa M Ellerby · 1998 to 2026
$13.8M
CELLULAR SENESCENCE AND CONTROL OF GENE EXPRESSIONR37AG009909 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CAMPISI, JUDITH · 1995 to 2015
$7.6M
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem CellsR01NS100529 · NINDS · BUCK INSTITUTE FOR RESEARCH ON AGING · PI Lisa M Ellerby · 2016 to 2026
$5.6M
Cellular senescence and control of gene expressionR56AG009909 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI CAMPISI, JUDITH · 2017 to 2017
$592k
NIA NIH HHS R37 AG009909NIA NIH HHS R56 AG009909NIA NIH HHS T32 AG000266NINDS NIH HHS R01 NS100529
6 · The paper itself

Abstract

Neurodegenerative diseases (ND) have been linked to the critical process in aging-cellular senescence. However, the temporal dynamics of cellular senescence in ND conditions is unresolved. Here, we show senescence features develop in human Huntington's disease (HD) neural stem cells (NSCs) and medium spiny neurons (MSNs), including the increase of p16

Indexed as

Cyclin-Dependent Kinase Inhibitor p16Forkhead Box Protein O3HumansHuntington DiseaseNeural Stem CellsNeuronsCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Forkhead Box Protein O3FOXO3 protein, humanneurodegenerative diseaseneuronal differentiationneuronal senescenceresponse mechanismstemporal dynamics

Identifiers

PMID33156570
PMCPMC7681055
OpenAlexW3096529369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.